Get the Stockscreener App
154.79
1.65%
2.52
Davita Inc stock is traded at $154.79, with a volume of 542.47K.
It is up +1.65% in the last 24 hours and up +8.96% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$152.27
Open:
$152.41
24h Volume:
542.47K
Relative Volume:
0.54
Market Cap:
$10.35B
Revenue:
$13.64B
Net Income/Loss:
$1.05B
P/E Ratio:
16.20
EPS:
9.555
Net Cash Flow:
$1.31B
1W Performance:
+3.53%
1M Performance:
+8.96%
6M Performance:
+14.19%
1Y Performance:
+9.31%
1-Day Range:
$150.51
$155.29
1-Week Range:
$148.52
$159.42
52-Week Range:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
154.79 | 10.18B | 13.64B | 1.05B | 1.31B | 9.555 |
|
HCA
Hca Healthcare Inc
|
544.41 | 121.16B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
244.80 | 21.12B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.03 | 13.05B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
202.31 | 12.51B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
212.05 | 12.39B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Jim Cramer on DaVita: “Haven’t Seen That Stock Do That Well In This Long” - Yahoo Finance
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long" - Finviz
Teachers Retirement System of The State of Kentucky Boosts Position in DaVita Inc. $DVA - MarketBeat
TD Asset Management Inc Purchases 26,602 Shares of DaVita Inc. $DVA - MarketBeat
How Berkshire Hathaway Performed During Buffett’s Final Quarter - Investing.com
DaVita Stock Leaps 39% In One Month, Time To Buy The Stock? - Trefis
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita, Inc. Hits New 52-Week High at USD 157.90 - Markets Mojo
DaVita, Inc. Hits New 52-Week High at USD 159.42 - Markets Mojo
DaVita Stock Analysis: A $243 per Share Valuation Model Target - TIKR.com
DaVita Inc. $DVA Shares Sold by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
DaVita Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
With DaVita Stock Surging, Have You Considered The Downside? - Trefis
DaVita at TD Cowen Conference: Strategic Growth Amid Challenges - Investing.com
Intech Investment Management Boosts DaVita Stock Holdings - National Today
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. (NYSE:DVA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amid a 64.85% Return on Equity - DirectorsTalk Interviews
Quantbot Technologies LP Has $3.88 Million Holdings in DaVita Inc. $DVA - MarketBeat
Intech Investment Management LLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVitaMeet the MentorGirls & Science - CBS News
DaVita (NYSE:DVA) Sets New 12-Month HighShould You Buy? - MarketBeat
Davita Healthcare stock hits 52-week high at 157.25 USD - Investing.com
Where Does DaVita Stock Rank Among Competitors? - Trefis
DaVita’s 20-Year Fortune Streak And What It Signals For Investors - Yahoo Finance
DaVita Inc.: Why This Quiet Healthcare Stock Just Got Loud for US Investors - AD HOC NEWS
Does DaVita Stock Lead the Pack? - Trefis
DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies - ACCESS Newswire
Vanguard Group Inc. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference - GuruFocus
DaVita, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
DaVita Stock After Earnings: Hidden Cash Machine or Value Trap? - AD HOC NEWS
Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative - simplywall.st
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
Is It Too Late To Consider DaVita (DVA) After Its Sharp 30 Day Surge - Yahoo Finance
DaVita Inc. (DVA): A Bull Case Theory - MSN
Aberdeen Group plc Decreases Stake in DaVita Inc. $DVA - MarketBeat
Layoff Watch: Can DaVita Inc continue delivering strong returnsJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
Wall Street Zen Upgrades DaVita (NYSE:DVA) to Buy - MarketBeat
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $2.56 Million Stock Holdings in DaVita Inc. $DVA - Defense World
Zacks.com featured highlights include DaVita, Ford, Centerra, Southwest Airlines and Patria Investments - Yahoo Finance
October 16th Options Now Available For DaVita (DVA) - Nasdaq
DaVita Stock Is Up 35% Since February. Here’s Where Shares Could Go in 2026 - TIKR.com
Skandinaviska Enskilda Banken AB publ Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - AOL.com
Berkshire's New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - GOBankingRates
A | Will DaVita Inc. stock benefit from M&A2025 Market Overview & Weekly High Return Stock Forecasts - mfd.ru
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):